NeoGenomics Inc (NEO)

NASDAQ HEALTHCARE
$10.52 +3.24% RSI 35 Neutral Add Alert

Moving Averages

SMA 200
$9.51
Price above

Company Profile

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.

Sector
HEALTHCARE
Industry
DIAGNOSTICS & RESEARCH
Market Cap
$1.08B
P/E Ratio
None
EPS
$-0.77
Beta
1.803
Dividend Yield
0.00%
52-Week High
$13.74
52-Week Low
$4.72

Similar stocks in DIAGNOSTICS & RESEARCH

TMO
Thermo Fisher Scientific Inc
RSI 62.0
ILMN
Illumina Inc
RSI 79.0
MTD
Mettler-Toledo International Inc
RSI 51.0
CSTL
Castle Biosciences Inc
RSI 47.0
FONR
Fonar Corp
RSI 79.0
CRL
Charles River Laboratories International Inc
RSI 61.0
BDSX
Biodesix Inc
RSI 64.0
NTRA
Natera Inc
RSI 62.0
WGS
GeneDx Holdings Corp - Class A
RSI 52.0
DGX
Quest Diagnostics Inc
RSI 36.0

Data last updated: May 14, 2026 at 7:25 AM EDT

Track NEO for free

Get e-mail RSI alerts when NeoGenomics Inc enters oversold or overbought territory. Free forever.

Add Alert